Cover Image

Adverse Events of Trivalent Influenza Vaccine among Health Care Workers in Iran

Show other versions (1)

"nBackground: To assess the frequency and type of adverse events after influenza vaccination in Iranian adults."nMethods: Health care workers in 7 medical centers received the influenza vaccine from October 2006 to February 2007 and followed by phone regarding symptoms experienced...

Full description

Saved in:

Bibliographic Details
Main Authors:	M Hajiabdolbaghi (Author), S Jafari (Author), AR Esteghamati (Author), MN Dadras (Author), MM Gouya (Author), S Jam (Author), H Emadi Koochak (Author), P Kheirandish (Author), S Shahriari (Author), B Moradmand Badie (Author)
Format:	Book
Published:	Tehran University of Medical Sciences, 2009-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adverse Events of Trivalent Influenza Vaccine among Health Care Workers in Iran
by: M Hajiabdolbaghi, et al.
Published: (2009)

Adverse Events of Interest Following Influenza Vaccination in the First Season of Adjuvanted Trivalent Immunization: Retrospective Cohort Study
by: Simon de Lusignan, et al.
Published: (2022)

Analysis of the adverse events following immunization with inactivated quadrivalent influenza vaccine from 2018 to 2020 in Zhejiang province, with a comparison to trivalent influenza vaccine
by: Huakun Lv, et al.
Published: (2021)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011)

Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015
by: Suvanna Asavapiriyanont, et al.
Published: (2018)

Rapid safety assessment of a seasonal intradermal trivalent influenza vaccine
by: Marc Demeulemeester, et al.
Published: (2017)

Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary disease
by: Yan Li, et al.
Published: (2021)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China
by: Zhaojun Mo, et al.
Published: (2017)

Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore
by: Yuk-Fai Lau, et al.
Published: (2017)

Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy
by: Kei Nakashima, et al.
Published: (2017)

Seroepidemiology of Human Parvovirus B19 in 5-25 Year Old Age People in Iran
by: V Salimi, et al.
Published: (2008)

Seroepidemiology of Human Parvovirus B19 in 5-25 Year Old Age People in Iran
by: V Salimi, et al.
Published: (2008)

Comparison of Multiplex Nested RT-PCR with Virus Isolation for Detection of Influenza Viruses A and B
by: T Mokhtari-Azad, et al.
Published: (2007)

Comparison of Multiplex Nested RT-PCR with Virus Isolation for Detection of Influenza Viruses A and B
by: T Mokhtari-Azad, et al.
Published: (2007)

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
by: Pablo Manuel Bianculli, et al.
Published: (2022)

Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy
by: Francesco Saverio Mennini, et al.
Published: (2018)

Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
by: Sandrine I. Samson, et al.
Published: (2019)

Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
by: Ilaria Loperto, et al.
Published: (2019)

Seropositivity of influenza A H1NI in mothers and infants following maternal vaccination with trivalent seasonal influenza vaccine after the 2009 pandemic
by: An-Shine Chao, et al.
Published: (2017)

Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial
by: Wayne M Sullender, ProfMD, et al.
Published: (2019)

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
by: Antonio Arbo, et al.
Published: (2022)

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model
by: Ming-Chin Yang, et al.
Published: (2017)

Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico
by: Guillermo M. Ruiz-Palacios, et al.
Published: (2020)

The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2-6 Months Infants in Iran: A National Study
by: Zaher Khazaei, et al.
Published: (2020)

Adverse drug events monitoring of live attenuated pandemic influenza vaccine
by: Pramod B Akat, et al.
Published: (2011)

Oral adverse events following COVID-19 and influenza vaccination in Australia
by: Abanoub Riad, et al.
Published: (2023)

Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
by: Anita J. Brogan, et al.
Published: (2017)

Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults
by: Ahmed Tawfik, et al.
Published: (2023)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
by: Xiaoqiang Liu, et al.
Published: (2022)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
by: Yuemei Hu, et al.
Published: (2019)

Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou, China
by: Yin Wang, et al.
Published: (2018)

Trend of Communicable Diseases in Iran from 1979 to 2008
by: MM Gouya
Published: (2009)

Trend of Communicable Diseases in Iran from 1979 to 2008
by: MM Gouya
Published: (2009)

Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season
by: Laurence Serradell, et al.
Published: (2021)

The Effect of Psycho-Social Problems on Risky Behaviors in People Living With HIV in Tehran, Iran
by: Mehrnaz Rasoolinejad, et al.
Published: (2018)

Expanded Programme on Immunization in Iran: Last 3 Decades Achievements from 1979 to 2008
by: MM Gouya
Published: (2009)

Expanded Programme on Immunization in Iran: Last 3 Decades Achievements from 1979 to 2008
by: MM Gouya
Published: (2009)

IMMUNOGENICITY AND SAFETY OF A TRIVALENT SUBUNIT IMMUNOADJUVANT INFLUENZA VACCINE IN CHILDREN WITH TYPE 1 DIABETES: RESULTS OF A PROSPECTIVE COMPARATIVE STUDY
by: Аlla A. Tarasova, et al.
Published: (2016)

Seasonal Influenza Vaccine Effectiveness (SIVE): an observational retrospective cohort study - exploitation of a unique community-based national-linked database to determine the effectiveness of the seasonal trivalent influenza vaccine
by: CR Simpson, et al.
Published: (2013)

Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults
by: Goran Stevanovic, et al.
Published: (2018)